Injectable solution at ph 7 containing at least one basal insulin, the pi of which is between 5.8 and 8.5, liraglutide, and a copolyamino acid carrying carboxylate charges and hydrophobic radicals
WO2020115334A1
Method for preparing a stable composition in the form of an injectable aqueous solution
US2019388515A1
Injectable solution at ph 7 comprising at least one basal insulin the pi of which is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
WO2020025826A1
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, at least one ionic species and an amphiphilic compound containing hydrophobic radicals
WO2020025825A1
Injectable solution having ph 7 and comprising human glucagon, at least one ionic species, and an amphiphilic compound bearing hydrophobic radicals
WO2020025824A1
Injectable solution at ph 7, comprising at least one basal insulin with a pi between 5.8 and 8.5, at least one ionic species, and an amphiphilic compound bearing hydrophobic radicals
WO2019243627A1
Device for injecting an insulin solution
WO2019243628A1
Injectable composition with a ph of 7 comprising a co-polyaminoacid bearing carboxylate charges and hydrophobic radicals and at least one basal insulin having at least a prandial effect and a basal effect
US2019274953A1
Ph 7 injectable solution comprising at least one basic insulin with a pi comprised from 5.8 to 8.5 and a co-polyaminoacide bearing carboxylate charges and hydrophobic radicals
US2020179489A1
Injectable solution at ph 7 comprising at least one basal insulin which pi is from 5.8 to 8.5 and a co-polyamino-acid bearing carboxylate charges and hydrophobic radicals and a limited amount of m-cresol
WO2019110773A1
Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals
EP3723728A1
Injectable solution with a ph of 7 comprising at least one basal insulin with a pi of between 5.8 and 8.5 and a co-polyaminoacid bearing carboxylate charges and hydrophobic radicals
WO2019110837A1
Compositions in the form of an injectable aqueous solution comprising human glucagon and a copolyamino acid
EP3740195A1
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid
AU2018380901A1
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid
CN111683675A
Compositions in the form of injectable aqueous solutions comprising human glucagon and a polyamino acid copolymer
WO2019110788A1
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid
SG11202005322RA
Injectable solution at ph 7 comprising at least one basal insulin having a pi of between 5.8 and 8.5 and a copolyamino acid carrying carboxylate charges and hydrophobic radicals
US2019275110A1
Compositions in the form of an injectale aqueous solution comprising human glucagon and a co-polyamino acid
WO2019115411A1
Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analogue and a copolyamino acid
